Based in the United States, EBVio is a startup.
EBVio is a preclinical therapeutics company developing novel precision medicines targeting Epstein-Barr virus-driven autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.